LKFT · Lakefront Biotherapeutics NV
Market Cap
1.72B EUR
Shares
65.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close26.3000 EUR
Open26.0000 EUR
Day25.7800–26.5200 EUR
52W close22.4800–31.2600 EUR
Avg vol 30d103K
Last earningsNov 11, 2026
DataJan 2020–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 22.4800 EUR
Now 26.3000 EUR · 44%
Range high 31.2600 EUR
vs 200-day avg +1%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XAMS:LKFT | +1.2% | +7.7% | +6.5% | -0.5% | -6.1% |
Exchange listing
- Market
- XAMS
- Ticker
- LKFT
- ISIN
- BE0003818359
- Security
- —
- Trading currency
- EUR
Company
- Website
- http://www.glpg.com/
- Investor relations
- https://lakefrontbio.com/investors/corporate-governance/
Other listings of this company
No other verified listings are available.
Latest trade
15-minute delayed Session complete26.3000 EUR
305 shares at 2026-10-05 15:35:20 UTC (17:35:20 local)
- Session
- 2026-10-05
- Open
- 26.0000
- High
- 26.5200
- Low
- 25.7800
- Volume
- 159,819
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2026-11-11 00:00 UTC | Third quarter 2026 results | Results publication |
Earnings calls
-
Earnings call · Q3 2026 2026-11-11 ScheduledThird quarter 2026 results
-
Conference · September 2026 2026-09-15 Audio TranscriptMorgan Stanley 24th Annual Global Healthcare Conference
-
Earnings call · Q2 2026 2026-08-10Half Year 2026 results
-
Earnings call · Q1 2026 2026-05-06 AudioFirst quarter 2026 results
-
Earnings call · Q4 2025 2026-02-24 AudioFull year 2025 Results